Last edition
News about "treatment of venous thromboembolism (VTE) "
Lupin Launches Generic Xarelto Rivaroxaban Oral Suspension in US
Global pharma major Lupin has announced the launch of Rivaroxaban for Oral Suspension, 1 mg/mL, in the United States.
Treatment Of Venous Thromboembolism (VTE) | 03/10/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members